When weight loss is rapid, part of what is lost is not fat. This is true of all significant weight loss, and it is true of GLP-1 agonist treatments: trials measure that approximately one quarter of weight lost is lean mass. Experts disagree on the severity of this figure, and we will report both positions. They do agree, however, on what must be done.
A consensus review published in Obesity Reviews, signed by teams from Mount Sinai, the Cleveland Clinic, Harvard, and UCLA, formulates two recommendations: adequate intake of quality proteins and micronutrients, if necessary through oral nutritional supplements, and resistance training. This article details these two approaches, and the very concrete difficulty of eating enough when appetite has disappeared.
The figure. A network meta-analysis of 22 trials and 2,258 participants measures lean mass loss representing approximately 25% of total weight loss; the SURMOUNT-1 sub-study by dual-energy X-ray absorptiometry found 75% fat mass and 25% lean mass, in both the treated group and placebo group. The debate. One review sees this as adaptive changes with improved muscle quality; the consensus review alerts to muscle loss equivalent to approximately twenty years of muscle aging in 68 to 72 weeks.
The agreement. Two approaches, equally important: quality proteins in sufficient quantity, with possible recourse to oral nutritional supplements, and resistance training. Micronutrients also matter when ingested quantities drop. The rule. Everything is decided with the team monitoring the treatment: only they know your situation, your lab results, and your medical history.
What the trials measure
Twenty-two randomized trials, totaling 2,258 adult participants with diabetes or overweight and obesity, were included. GLP-1 receptor agonists significantly reduced total weight by 3.55 kg, fat mass by 2.95 kg, and lean mass by 0.86 kg, with lean mass loss representing approximately 25 percent of total weight loss. However, relative lean mass, defined as the percentage change from baseline, was not altered. The molecules most effective on weight and fat mass were among the least effective at preserving lean mass.
Karakasis P, Patoulias D, Fragakis N, Mantzoros CS. Metabolism 2024;164:156113. DOI: 10.1016/j.metabol.2024.156113
A substudy of the SURMOUNT-1 trial, published in 2025, measured body composition by absorptiometry in 160 participants at 72 weeks. It provides the comparison point often missing from the debate: of the weight lost, approximately 75% was fat mass and 25% was lean mass, and this proportion was the same in the treated group and in the placebo group. In other words, the distribution is not specific to the medication: it is that of weight loss.
The review in Diabetes, Obesity and Metabolism highlights a technical nuance that matters: lean mass measured by absorptiometry includes not only muscle, but also organs, bone, fluids, and water contained in adipose tissue. Part of what appears as lean mass loss is water and supporting tissue that accompanied the fat. This is one reason why experts do not all interpret this figure the same way.
The expert debate
The reassuring reading. The review of Diabetes, Obesity and Metabolism, which relies on magnetic resonance imaging studies, estimates that changes in skeletal muscle appear to be adaptive : the reduction in muscle volume corresponds to what is expected given age, disease, and weight loss, and the improvement in insulin sensitivity and muscle fat infiltration contribute to better muscle quality, which reduces the probability of loss of strength and function. Its authors note nonetheless that advanced age and disease severity can influence the choice of candidates, due to the risk of sarcopenia.
Available data suggest that participants in clinical trials receiving these obesity treatments lost 10 percent or more of their muscle mass during interventions of 68 to 72 weeks, which is approximately equivalent to twenty years of age-related muscle loss. The ability to maintain muscle mass during weight loss induced by caloric restriction is influenced by two key factors: nutrition and physical exercise. Nutritional management must ensure sufficient intake and absorption of high-quality protein and micronutrients, which may require the use of oral nutritional supplements. Moreover, concurrent physical activity, particularly resistance training, has proven effective in minimizing the loss of muscle mass and function during weight reduction treatment.
Mechanick JI, Butsch WS, Christensen SM, et al. Obes Rev 2024;26(1):e13841. DOI: 10.1111/obr.13841
These authors, from Mount Sinai, Cleveland Clinic, Harvard, UCLA, and Pennington, are considerably more concerned. They note that clinical adoption of these treatments has been faster than the updating of practice guidelines, and that many patients could consequently not benefit from adequate nutritional support. Their conclusion is a directive: all patients receiving these treatments should participate in a program combining sufficient protein and micronutrient intake and resistance training.
The two pillars of consensus
Proteins
The recommendation is to ensure sufficient intake and absorption of high-quality protein. The review does not set a single figure, and that is consistent: the need depends on weight, age, degree of restriction, and medical situation. Two practical principles follow from this. First, quality : a complete protein, containing all essential amino acids—eggs, fish, meat, dairy products, or whey isolate. Next, distribution : regular intake at each meal is preferable to one large portion in the evening, a principle established in nutrition and particularly relevant when each meal is reduced.
Muscle strengthening
The review places it at the same level as nutrition, and this is the point that mainstream articles most often overlook. A muscle that is used is a muscle that the body has a reason to preserve during restriction. Two to three sessions per week, working against resistance, bodyweight, resistance bands, or weights, are enough to send this signal. Our creatine guide further details what is established about strength and muscle mass in training, in the general population.
| What the consensus review says | In practice |
|---|---|
| Sufficient intake of high-quality protein | Complete proteins at each meal; numeric target to be set with your doctor or dietitian |
| Possible use of oral nutritional supplements | A protein drink when food volume is no longer manageable |
| Sufficient micronutrient intake | Varied diet despite small quantities; blood tests and supplementation decided medically |
| Resistance training | Two to three sessions per week, progressive, adapted to your condition |
| Complete care management program | Discuss it with the treatment team rather than managing alone |
Eating enough when appetite has disappeared
There is a difficulty that recommendations name without detailing it, yet it is the heart of the problem: when appetite is greatly reduced and satiety arrives after just a few bites, reaching sufficient protein intake becomes an exercise. The foods richest in protein are also the most satiating and the longest to digest, which paradoxically makes them more difficult to consume in quantity. This is exactly why the consensus review mentions oral nutritional supplements : a liquid passes where a solid food no longer does.
22.9 g of protein per 30 g serving, for 117 kcal, 1.8 g carbohydrates and 2 g fat, in 200 ml of water. A whey isolate, a complete protein, that addresses the difficulty described above: delivering high-quality protein when food volume no longer works. To be incorporated into your daily intake, in agreement with the team following your treatment.
View the Whey IsolateNutritional supplement, does not replace a balanced meal or treatment. To be discussed with your doctor or dietitian, particularly in case of kidney insufficiency or lactose intolerance.
Other nutritional questions
Micronutrients
The consensus review places them explicitly alongside protein, without detailing expected deficiencies. The logic is straightforward: less food, fewer vitamins and minerals. In practice, this means prioritizing nutritional density in the small quantities that are consumed, colorful vegetables, eggs, fish, legumes. And it especially means that the question of a blood test and possible supplementation arises at doctor monitoring the treatment, based on test results, rather than blindly.
Transit
Digestive disorders are the most common side effects of these treatments, and reduced food intake also lowers fiber consumption. The usual strategies remain hydration, vegetables, legumes, and physical activity. A soluble fiber like psyllium can help, by increasing doses gradually, with plenty of water, and spacing it out from medications. Persistent constipation or intense abdominal pain should be reported to the doctor without delay.
Hair
Diffuse hair loss is common after any rapid weight loss, including after bariatric surgery or very restrictive dieting. It is most often temporary and linked to the restriction itself, particularly to insufficient intake of protein, iron, and zinc. It should be discussed with the doctor, who can check ferritin levels ; our article on hair loss details the active ingredients that have evidence.
We did not identify any trial of creatine, of collagen or of multivitamins conducted specifically in people undergoing GLP-1 agonist treatment. We cannot therefore make any claims about these products in this specific context, and we will not. What is established is so in the general population and appears in our respective guides. Whether any of them has a place in your situation is a question for the team following your care.
Intense or persistent abdominal pain ; repeated vomiting preventing eating or drinking ; unusual and progressively worsening fatigue or muscle weakness. And in general, anything that concerns you : it is the team that prescribed the treatment that can judge, not an article.
Frequently asked questions
Muscle
Do you lose muscle with GLP-1 treatment?
Part of the weight loss is lean mass, as with any rapid weight loss. A network meta-analysis of 22 randomized trials and 2,258 participants, published in Metabolism, measured a loss of lean mass representing approximately 25% of total weight loss, while noting that relative lean mass, as a percentage of body weight, is unchanged. The sub-study by absorptiometry from the SURMOUNT-1 trial found the same proportion: approximately 75% fat mass and 25% lean mass, in both the treatment group and placebo group.
Is this muscle loss serious?
Opinions differ, and it's important to say so. A review published in Diabetes, Obesity and Metabolism suggests that the muscular changes observed on imaging appear adaptive: the reduction in muscle volume corresponds to what would be expected given the weight lost, and muscle quality improves with decreased fatty infiltration. A consensus review published in Obesity Reviews is more alarming: it reports that participants lost 10% or more of their muscle mass in 68 to 72 weeks, equivalent to approximately twenty years of age-related muscle loss, and alerts to functional consequences. Both teams agree on one point: protein and exercise limit this loss.
Should I do strength training during treatment?
This is the second recommendation from the consensus review, at the same level as nutrition: concurrent physical activity, particularly resistance training, has been shown to effectively minimize loss of muscle mass and function during weight loss. The authors recommend that all patients receiving these treatments participate in a comprehensive program combining sufficient protein and micronutrient intake with resistance training. This is not an optional supplement to the treatment, it is a component of its success.
Protein
How much protein is needed during rapid weight loss?
The consensus review fromObesity Reviews recommends ensuring sufficient intake and absorption of high-quality protein and micronutrients, and specifies that this may require the use of oral nutritional supplements. It does not set a single figure, because the requirement depends on weight, age, and degree of restriction. The practical rule is to spread protein across meals rather than concentrating it all in the evening, and to have a specific target set by the doctor or dietitian managing the treatment, who knows your situation.
Why is it difficult to eat enough protein during treatment?
Because these treatments work by reducing appetite and slowing gastric emptying: the sensation of satiety arrives very quickly and lasts a long time. Protein-rich foods—meat, fish, legumes—are also the most satiating and slowest to digest, which makes them paradoxically more difficult to consume in sufficient quantities. This is precisely why the consensus review mentions oral nutritional supplements: a protein drink provides 20 to 25 g of protein in a volume that the stomach accepts more easily than a steak.
Is creatine useful in this context?
We have not identified any creatine trials conducted specifically in people receiving GLP-1 treatment, and we therefore cannot make any claims on this point. What is established is its effect on strength and muscle mass in combination with resistance training in the general population, detailed in our creatine guide. Since resistance training is precisely what the consensus review recommends, the question of creatine naturally arises, and should be addressed with the doctor or dietitian managing the treatment.
Other effects
Are micronutrients a problem?
When you eat much less, you also ingest fewer vitamins and minerals, and the consensus review explicitly places sufficient micronutrient intake alongside protein. It does not detail any specific expected deficiency. In practice, this is the question to ask the doctor managing the treatment: depending on your diet, blood tests can check iron, vitamin D, and vitamin B12, and supplementation can be decided based on these results rather than blindly.
What can be done about constipation?
Digestive disorders are the most frequent adverse effects of these treatments, and constipation is part of them. It is also favored by the reduction in amounts consumed, and therefore in fiber. The usual approaches are hydration, vegetables and legumes, and movement. A soluble fiber such as psyllium can help, by gradually increasing doses with plenty of water, and spacing it apart from medications. Any persistent constipation, or any severe abdominal pain, should be reported to the doctor managing the treatment without delay.
And hair loss?
Diffuse hair loss frequently occurs after rapid weight loss, regardless of the cause, including after bariatric surgery or very restrictive dieting. It is most often temporary and linked to the restriction itself, particularly to insufficient intake of protein, iron, and zinc, rather than to the medication. This should be discussed with the doctor, who can check ferritin levels, and our article on hair loss details the active ingredients that have supporting data.
What should I remember about nutrition during these treatments?
That approximately one-quarter of weight lost is lean mass, and this is the typical proportion of weight loss. That experts disagree on the severity, between adaptive changes and concerns about the equivalent of twenty years of muscle loss. That they agree on two key approaches: quality protein in sufficient quantity, if needed as oral nutritional supplements, and resistance training. That micronutrients also matter when you eat much less. And that all of this should be decided with the team managing your treatment, not alone.
Glossary
- Lean mass
- Everything that is not fat: muscle, but also organs, bones, fluids, and water contained in adipose tissue.
- Absorptiometry (DXA)
- Reference examination measuring fat mass, lean mass, and bone mass separately; used in the SURMOUNT-1 sub-study.
- Sarcopenia
- Loss of muscle mass and function, associated with decreased strength, mobility, and independence.
- Oral nutritional supplements
- Concentrated protein and nutrient preparations, in liquid or powder form; explicitly mentioned by the consensus review.
- Resistance training
- Muscle work against a load: body weight, resistance bands, machines, or dumbbells.
- Network meta-analysis
- Method comparing multiple treatments with each other, even without trials that directly confronted them.
- Complete protein
- Protein containing all essential amino acids: eggs, fish, meat, dairy products, whey isolate.
Sources
The studies cited below were identified via PubMed.
- Mechanick JI, Butsch WS, Christensen SM, Hamdy O, Li Z, Prado CM, Heymsfield SB. Strategies to minimize muscle loss with the use of incretin-mimetic medications in obesity treatment. Obesity Reviews, 2025;26(1):e13841. DOI
- Karakasis P, Patoulias D, Fragakis N, Mantzoros CS. Effect of GLP-1 receptor agonists and co-agonists on body composition: systematic review and network meta-analysis. Metabolism, 2024;164:156113. DOI
- Look M, Dunn JP, Kushner RF, et al. Changes in body composition during weight reduction with tirzepatide in the SURMOUNT-1 study in adults with obesity or overweight. Diabetes, Obesity and Metabolism, 2025;27(5):2720-2729. DOI
- Neeland IJ, Linge J, Birkenfeld AL. Changes in lean mass under GLP-1-based therapies and mitigation strategies. Diabetes, Obesity and Metabolism, 2024;26 Suppl 4:16-27. DOI


